|
Sources:
* Berman M, Erman A, Ben Gal T, et al. Coenzyme Q10 in patients with end-stage heart
failure awaiting cardiac transplantation: a randomized, placebo-controlled study. Clin
Cardiol 2004;27(5):295-299.
* Burke BE, Neuenschwander R, Olson RD. Randomized, double-blind, placebo-controlled trial
of coenzyme Q10 in isolated systolic hypertension. South Med J 2001;94(11):1112-1117.
* Damian MS, Ellenberg D, Gildemeister R, et al. Coenzyme Q10 combined with mild
hypothermia after cardiac arrest: a preliminary study. Circulation 2004 Nov
9;110(19):3011-6.
* Hershey AD, Powers SW, Vockell AL, et al. Coenzyme Q10 deficiency and response to
supplementation in pediatric and adolescent migraine. Headache 2007 Jan;47(1):73-80.
* Hodgson JM, Watts GF, Playford DA, et al. Coenzyme Q(10) improves blood pressure and
glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr
2002;56(11):1137-1142.
* Khan M, Gross J, Haupt H, et al. A pilot clinical trial of the effects of coenzyme Q10
on chronic tinnitus aurium. Otolaryngol Head Neck Surg 2007 Jan;136(1):72-7.
* Langsjoen H, Langsjoen P, Langsjoen P, et al. Usefulness of coenzyme Q10 in clinical
cardiology: a long-term study. Mol Aspects Med 1994;15 Suppl:s165-s175.
* Miyake Y, Shouzu A, Nishikawa M, et al. Effect of treatment with
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in
diabetic patients. Arzneimittelforschung 1999;49(4):324-329.
* Morisco C, Trimarco B, Condorelli M. Effect of coenzyme Q10 therapy in patients with
congestive heart failure: a long-term multicenter randomized study. Clin Investig
1993;71(8 Suppl):S134-S136.
* Reid MS, Casadonte P, Baker S, et al. A placebo-controlled screening trial of
olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine
dependence. Addiction 2005 Mar;100 Suppl 1:43-57.
* Rosenfeldt FL, Haas SJ, Krum H, et al. Coenzyme Q10 in the treatment of hypertension: a
meta-analysis of the clinical trials. J Hum Hypertens 2007 Apr;21(4):297-306.
* Sandor PS, Di Clemente L, Coppola G, et al. Efficacy of coenzyme Q10 in migraine
prophylaxis: a randomized controlled trial. Neurology 2-22-2005;64(4):713-715.
* Shults CW, Oakes D, Kieburtz K, et al. Effects of coenzyme Q10 in early Parkinson
disease: evidence of slowing of the functional decline. Arch Neurol 2002;59(10):1541-1550.
* Singh RB, Wander GS, Rastogi A, et al. Randomized, double-blind placebo-controlled trial
of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc Drugs Ther
1998;12(4):347-353.
* The NINDS NET-PD Investigators. A randomized clinical trial of coenzyme Q10 and GPI-1485
in early Parkinson disease. Neurology 2007 Jan 2;68(1):20-8.
|